Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01152268 · ClinicalTrials.gov registry record
Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool
A clinical trial of Cancer, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 282
- Enrollment target
- 9
- Study locations
NCT01152268 is a study of Cancer that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 282 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (92% lower). The trial reports 9 study locations across 8 states.
The verdict
NCT01152268, a study of Cancer, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 282 participants
- Enrollment target
- 9
- Study locations
Study Summary
Despite the known adverse effects of specific cancer treatments on fertility, only 18-26% of at-risk adolescents and young men cryopreserve sperm prior to cancer treatment in the US: These already less than optimal rates of sperm banking are even lower among adolescents who have increased anxiety at cancer diagnosis, are lower in age and socioeconomic status, of Evangelical religious orientation, or are diagnosed with leukemia/lymphoma: It is not clear why sperm banking is underutilized, particularly in light of the high priority that survivors of childhood cancer place on fertility and the high psychological distress associated with fertility loss. Studies addressing sperm banking among adults with cancer suggest that factors such as poor physician communication and the resulting lack of fertility-risk knowledge by patients contributes to the low frequency of sperm cryopreservation. No well-designed studies have examined risk factors associated with failure to bank sperm among adolescents with cancer, a developmentally distinct population ripe for intervention. This study plans to enroll 206 adolescent males and 412 parents/guardians.
Conditions Studied
Study Locations (9)
California
- City of Hope - Duarte
- Mattel Children's Hospital - Los Angeles
Georgia
- Children's Healthcare of Atlanta - Atlanta
Massachusetts
- Dana-Farber Cancer Institute/Children's Hospital Boston - Boston
Michigan
- The University of Michigan - Ann Arbor
Tennessee
- St. Jude Children's Research Hospital - Memphis
Texas
- Cook Children's Medical Center - Fort Worth
Utah
- Primary Children's Medical Center - Salt Lake City
Ontario
- The Hospital for Sick Children - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 282 participants |
| Start Date | 2010-07 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01152268
The ClinicalTrials.gov registry entry for NCT01152268 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 282 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (92% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01152268 reports 9 study locations spanning 8 distinct geographic areas - top geographies include California, Georgia, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT01152268 about?
NCT01152268 is a clinical study titled "Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool". Despite the known adverse effects of specific cancer treatments on fertility, only 18-26% of at-risk adolescents and young men cryopreserve sperm prior to cancer treatment in the US: These already less than optimal rates of sperm banking are even lower among adolescents who have increased anxiety at...
What is the current status of trial NCT01152268?
This trial is currently completed. The enrollment target is 282 participants. The study started on 2010-07. Estimated completion is 2014-06.
What conditions does trial NCT01152268 study?
This clinical trial studies the following conditions: Cancer.
Who is sponsoring clinical trial NCT01152268?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01152268 being conducted?
This trial has 9 study locations across California, Georgia, Massachusetts, Michigan, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.